# PINX1

## Overview
The PINX1 gene encodes the protein PIN2 (TERF1) interacting telomerase inhibitor 1, which is a crucial component in the regulation of telomerase activity and maintenance of genomic stability. As a telomerase inhibitor, the PINX1 protein plays a significant role in preventing excessive telomere elongation by interacting with telomeric proteins such as TRF1 and the telomerase catalytic component TERT. This interaction is vital for maintaining telomere homeostasis and preventing genomic instability, which is often associated with cancer (Soohoo2011Telomerase; Zhou2011PinX1:). Beyond its role in telomere regulation, PINX1 is involved in chromosome segregation during mitosis, acting as a microtubule-binding protein that stabilizes kinetochore-microtubule attachments (Yuan2009PinX1). The protein's interactions with various cellular components underscore its multifaceted role in cellular processes, and alterations in its expression have been linked to several cancers, highlighting its potential as a prognostic marker and therapeutic target (Shi2015PinX1; Zhou2011The).

## Structure
The PINX1 protein is a 328-amino acid protein known for its role as a telomerase inhibitor and its interaction with telomeric proteins. It contains several important domains that contribute to its function. The C-terminal region of PINX1, specifically the last 75 amino acids, includes the TRF1-interacting domain (TID), which is crucial for binding to the telomeric protein TRF1. Within this domain, a 20-amino acid fragment (C20) spanning residues 291 to 310 is both necessary and sufficient for the interaction with TRF1. This fragment contains several positively charged residues, such as Lys-292, Lys-294, Lys-295, and Arg-297, which are essential for the interaction (Soohoo2011Telomerase).

PINX1 also has a central domain that is important for its localization to kinetochores during mitosis, where it interacts with proteins like Hec1 and CENP-E, indicating its role in chromosome segregation (Yuan2009PinX1). The N-terminal region of PINX1 includes a glycine-rich domain, known as the G-patch, which is shared by select RNA-binding proteins and is involved in its interaction with telomerase components (Banik2004Characterization). The protein is known to undergo post-translational modifications, such as phosphorylation, which may influence its function and interactions. Splice variant isoforms of PINX1 can result in structural and functional diversity, although specific details on these variants are not provided in the context.

## Function
The PINX1 gene encodes a protein that plays a crucial role in maintaining genomic stability in healthy human cells. PINX1 functions primarily as a telomerase inhibitor, regulating telomerase activity to prevent excessive telomere elongation. It achieves this by directly binding to the telomerase catalytic component, TERT, and interacting with TRF1, a telomeric DNA-binding protein, to localize to telomeres (Soohoo2011Telomerase; Zhou2011PinX1:). This interaction is essential for maintaining telomere homeostasis, as it prevents abnormal telomere elongation, which is associated with genomic instability and cancer (Zhou2011PinX1:; Johnson2011PinX1).

In addition to its role in telomere maintenance, PINX1 is involved in chromosome segregation during mitosis. It acts as a microtubule-binding protein, essential for stabilizing kinetochore-microtubule attachments, which are crucial for accurate chromosome segregation. PINX1 localizes to the kinetochores during mitosis, ensuring proper chromosome alignment and segregation (Yuan2009PinX1). The loss of PINX1 function can lead to chromosome segregation errors, such as anaphase chromatid bridges and micronuclei formation, highlighting its role in maintaining chromosome stability (Yuan2009PinX1).

## Clinical Significance
Alterations in the expression of the PINX1 gene have significant clinical implications in various cancers. PINX1 is located on chromosome 8p23, a region frequently exhibiting loss of heterozygosity in several cancers, including breast, liver, lung, and gastrointestinal cancers (Zhou2011The). Reduced expression of PINX1 is associated with telomerase activation, telomere elongation, and chromosome instability, contributing to tumorigenesis (Zhou2011The). In breast cancer, low PINX1 expression correlates with lymph node metastasis, higher histology grade, and poorer survival outcomes, suggesting its potential as a prognostic marker (Shi2015PinX1).

In non-small cell lung cancer (NSCLC), PINX1 silencing increases tumor growth and affects cell cycle regulation through the p15/cyclin D1 pathway (Tian2017The). In cervical squamous cell carcinomas (CSCC), high PINX1 expression is linked to resistance to paclitaxel chemotherapy, indicating its role in drug sensitivity (Tian2014The). In renal cell carcinoma (RCC), decreased PINX1 expression is associated with advanced disease characteristics and poor survival, highlighting its role as a suppressor of metastasis (Hou2019PinX1). In bladder urothelial carcinoma, positive PINX1 expression is linked to better survival outcomes, acting as a tumor suppressor by inhibiting telomerase activity and the p16/cyclin D1 pathway (Liu2013PinX1).

## Interactions
PINX1 interacts with several proteins, playing a significant role in various cellular processes. It binds to the Prp43 RNA helicase, activating its ATPase and helicase activities. This interaction is mediated through the G-patch domain of PINX1, which is crucial for binding and activation, although the Prp43 OB fold domain is not essential for binding (Chen2014The; Mouffok2020The). PINX1 also interacts with Nucleolin during mitosis, forming a complex that is important for chromosome congression. This interaction occurs at the chromosome periphery and is essential for proper chromosome segregation (Li2009PinX1).

In the context of telomere regulation, PINX1 interacts with TRF1, a telomeric DNA-binding protein. This interaction is crucial for recruiting PINX1 to telomeres, where it inhibits telomere elongation by telomerase. The interaction is mediated by a 20-amino acid sequence in PINX1, with specific residues being critical for binding (Soohoo2011Telomerase). PINX1 also facilitates the loading of NPM to hTERT during the S phase, which is important for telomerase activation (Ho2019The). These interactions highlight PINX1's multifaceted role in cellular regulation.


## References


[1. (Hou2019PinX1) Pingfu Hou, Hailong Li, Hongmei Yong, Fang Chen, Sufang Chu, Junnian Zheng, and Jin Bai. Pinx1 represses renal cancer angiogenesis via the mir-125a-3p/vegf signaling pathway. Angiogenesis, 22(4):507–519, June 2019. URL: http://dx.doi.org/10.1007/s10456-019-09675-z, doi:10.1007/s10456-019-09675-z. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10456-019-09675-z)

[2. (Tian2017The) Xiao-Peng Tian, Xiao-Han Jin, Mei Li, Wei-Juan Huang, Dan Xie, and Jia-Xing Zhang. The depletion of pinx1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin d1 pathway. Molecular Cancer, April 2017. URL: http://dx.doi.org/10.1186/s12943-017-0637-4, doi:10.1186/s12943-017-0637-4. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s12943-017-0637-4)

[3. (Banik2004Characterization) Soma S.R. Banik and Christopher M. Counter. Characterization of interactions between pinx1 and human telomerase subunits htert and htr. Journal of Biological Chemistry, 279(50):51745–51748, December 2004. URL: http://dx.doi.org/10.1074/jbc.m408131200, doi:10.1074/jbc.m408131200. This article has 67 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m408131200)

[4. (Chen2014The) Y.-L. Chen, R. Capeyrou, O. Humbert, S. Mouffok, Y. A. Kadri, S. Lebaron, A. K. Henras, and Y. Henry. The telomerase inhibitor gno1p/pinx1 activates the helicase prp43p during ribosome biogenesis. Nucleic Acids Research, 42(11):7330–7345, May 2014. URL: http://dx.doi.org/10.1093/nar/gku357, doi:10.1093/nar/gku357. This article has 40 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gku357)

[5. (Mouffok2020The) Saïda Mouffok, Régine Capeyrou, Kamila Belhabich-Baumas, Clément Joret, Anthony K. Henras, Odile Humbert, and Yves Henry. The g-patch activators pfa1 and pinx1 exhibit different modes of interaction with the prp43 rna helicase. RNA Biology, 18(4):510–522, October 2020. URL: http://dx.doi.org/10.1080/15476286.2020.1818458, doi:10.1080/15476286.2020.1818458. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15476286.2020.1818458)

[6. (Yuan2009PinX1) Kai Yuan, Na Li, Kai Jiang, Tongge Zhu, Yuda Huo, Chong Wang, Jing Lu, Andrew Shaw, Kelwyn Thomas, Jiancun Zhang, David Mann, Jian Liao, Changjiang Jin, and Xuebiao Yao. Pinx1 is a novel microtubule-binding protein essential for accurate chromosome segregation. Journal of Biological Chemistry, 284(34):23072–23082, August 2009. URL: http://dx.doi.org/10.1074/jbc.M109.001990, doi:10.1074/jbc.m109.001990. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M109.001990)

[7. (Ho2019The) Sai-Tim Ho, Rui Jin, Derek Hang-Cheong Cheung, Jun-Jian Huang, and Pang-Chui Shaw. The pinx1/npm interaction associates with htert in early-s phase and facilitates telomerase activation. Cell &amp; Bioscience, June 2019. URL: http://dx.doi.org/10.1186/s13578-019-0306-y, doi:10.1186/s13578-019-0306-y. This article has 5 citations.](https://doi.org/10.1186/s13578-019-0306-y)

[8. (Liu2013PinX1) Jian-Ye Liu, Dong Qian, Li-Ru He, Yong-Hong Li, Yi-Ji Liao, Shi-Juan Mai, Xiao-Peng Tian, Yan-Hui Liu, Jia-Xing Zhang, Hsiang-Fu Kung, Yi-Xin Zeng, Fang-Jian Zhou, and Dan Xie. Pinx1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin d1 pathway. Molecular Cancer, November 2013. URL: http://dx.doi.org/10.1186/1476-4598-12-148, doi:10.1186/1476-4598-12-148. This article has 23 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-12-148)

[9. (Shi2015PinX1) Meilin Shi, Menghan Cao, Jun Song, Qinghua Liu, Hailong Li, Fei Meng, Zhenqiang Pan, Jin Bai, and Junnian Zheng. Pinx1 inhibits the invasion and metastasis of human breast cancer via suppressing nf-κb/mmp-9 signaling pathway. Molecular Cancer, March 2015. URL: http://dx.doi.org/10.1186/s12943-015-0332-2, doi:10.1186/s12943-015-0332-2. This article has 47 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s12943-015-0332-2)

[10. (Zhou2011The) Xiao Zhen Zhou, Pengyu Huang, Rong Shi, Tae Ho Lee, Gina Lu, Zhihong Zhang, Roderick Bronson, and Kun Ping Lu. The telomerase inhibitor pinx1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice. Journal of Clinical Investigation, 121(4):1266–1282, April 2011. URL: http://dx.doi.org/10.1172/jci43452, doi:10.1172/jci43452. This article has 49 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci43452)

[11. (Soohoo2011Telomerase) Christina Y. Soohoo, Rong Shi, Tae Ho Lee, Pengyu Huang, Kun Ping Lu, and Xiao Zhen Zhou. Telomerase inhibitor pinx1 provides a link between trf1 and telomerase to prevent telomere elongation. Journal of Biological Chemistry, 286(5):3894–3906, February 2011. URL: http://dx.doi.org/10.1074/jbc.M110.180174, doi:10.1074/jbc.m110.180174. This article has 65 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M110.180174)

[12. (Zhou2011PinX1:) Xiao Zhen Zhou. Pinx1: a sought-after major tumor suppressor at human chromosome 8p23. Oncotarget, 2(10):810–819, October 2011. URL: http://dx.doi.org/10.18632/oncotarget.339, doi:10.18632/oncotarget.339. This article has 15 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.339)

[13. (Li2009PinX1) Na Li, Kai Yuan, Feng Yan, Yuda Huo, Tongge Zhu, Xing Liu, Zhen Guo, and Xuebiao Yao. Pinx1 is recruited to the mitotic chromosome periphery by nucleolin and facilitates chromosome congression. Biochemical and Biophysical Research Communications, 384(1):76–81, June 2009. URL: http://dx.doi.org/10.1016/j.bbrc.2009.04.077, doi:10.1016/j.bbrc.2009.04.077. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2009.04.077)

[14. (Tian2014The) Xiao-Peng Tian, Dong Qian, Li-Ru He, He Huang, Shi-Juan Mai, Chang-Peng Li, Xiao-Xia Huang, Mu-Yan Cai, Yi-Ji Liao, Hsiang-fu Kung, Yi-Xin Zeng, and Dan Xie. The telomere/telomerase binding factor pinx1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas. Cancer Letters, 353(1):104–114, October 2014. URL: http://dx.doi.org/10.1016/j.canlet.2014.07.012, doi:10.1016/j.canlet.2014.07.012. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2014.07.012)

[15. (Johnson2011PinX1) F. Brad Johnson. Pinx1 the tail on the chromosome. Journal of Clinical Investigation, 121(4):1242–1244, April 2011. URL: http://dx.doi.org/10.1172/JCI57024, doi:10.1172/jci57024. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/JCI57024)